<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Arthritis Treated with Alternative Medicine &#187; Ra</title>
	<atom:link href="http://www.sayno2arthritis.com/blog/tag/ra/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.sayno2arthritis.com/blog</link>
	<description>Arthritis Help, and How it can be Treated Successfully  with Alternative Medicine</description>
	<lastBuildDate>Mon, 06 Sep 2010 07:13:46 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Rheumatoid Arthritis Linked To Vitamin D Deficiency</title>
		<link>http://www.sayno2arthritis.com/blog/rheumatoid-arthritis-linked-to-vitamin-d-deficiency/</link>
		<comments>http://www.sayno2arthritis.com/blog/rheumatoid-arthritis-linked-to-vitamin-d-deficiency/#comments</comments>
		<pubDate>Fri, 09 Apr 2010 07:00:00 +0000</pubDate>
		<dc:creator>Arthritis / Rheumatology News From Medical News Today</dc:creator>
				<category><![CDATA[Alternative medicine]]></category>
		<category><![CDATA[Acupuncture]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Autoimmune Disease]]></category>
		<category><![CDATA[Boston University School]]></category>
		<category><![CDATA[Boston University School Of Public Health]]></category>
		<category><![CDATA[chinese medicine]]></category>
		<category><![CDATA[Environmental Health Perspectives]]></category>
		<category><![CDATA[Health Researcher]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[School Of Public Health]]></category>
		<category><![CDATA[Spatial Analysis]]></category>
		<category><![CDATA[Vitamin D Deficiency]]></category>
		<category><![CDATA[Vitamin Deficiency]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3zYY</guid>
		<description><![CDATA[Women living in the northeastern United States are more likely to develop rheumatoid arthritis (RA), suggesting a link between the autoimmune disease and vitamin D deficiency, says a new study led by a Boston University School of Public Health researcher. In the paper, which appears online in the journal Environmental Health Perspectives, a spatial analysis led by Dr...<p><a href="http://www.sayno2arthritis.com/blog/rheumatoid-arthritis-linked-to-vitamin-d-deficiency/">Rheumatoid Arthritis Linked To Vitamin D Deficiency</a> is a post from: <a href="http://www.sayno2arthritis.com/blog">Arthritis Treated with Alternative Medicine</a></p>
]]></description>
		<wfw:commentRss>http://www.sayno2arthritis.com/blog/rheumatoid-arthritis-linked-to-vitamin-d-deficiency/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CBio Secures Another Clinical Trial Milestone</title>
		<link>http://www.sayno2arthritis.com/blog/cbio-secures-another-clinical-trial-milestone/</link>
		<comments>http://www.sayno2arthritis.com/blog/cbio-secures-another-clinical-trial-milestone/#comments</comments>
		<pubDate>Fri, 12 Mar 2010 09:00:00 +0000</pubDate>
		<dc:creator>Arthritis / Rheumatology News From Medical News Today</dc:creator>
				<category><![CDATA[arthritis news]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Asx]]></category>
		<category><![CDATA[Autoimmune Diseases]]></category>
		<category><![CDATA[Cbz]]></category>
		<category><![CDATA[Clinical Trial]]></category>
		<category><![CDATA[Drug Development Company]]></category>
		<category><![CDATA[Drug Therapy]]></category>
		<category><![CDATA[Limited]]></category>
		<category><![CDATA[Milestone]]></category>
		<category><![CDATA[New Generation]]></category>
		<category><![CDATA[Option Agreement]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3yQ5</guid>
		<description><![CDATA[Australian drug development company CBio Limited (ASX: CBZ) announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA)...<p><a href="http://www.sayno2arthritis.com/blog/cbio-secures-another-clinical-trial-milestone/">CBio Secures Another Clinical Trial Milestone</a> is a post from: <a href="http://www.sayno2arthritis.com/blog">Arthritis Treated with Alternative Medicine</a></p>
]]></description>
		<wfw:commentRss>http://www.sayno2arthritis.com/blog/cbio-secures-another-clinical-trial-milestone/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rheumatologists Have Plenty Of Choice Among Biologic Agents For RA &#8211; Where Will Actemra Find Its Niche?</title>
		<link>http://www.sayno2arthritis.com/blog/rheumatologists-have-plenty-of-choice-among-biologic-agents-for-ra-where-will-actemra-find-its-niche/</link>
		<comments>http://www.sayno2arthritis.com/blog/rheumatologists-have-plenty-of-choice-among-biologic-agents-for-ra-where-will-actemra-find-its-niche/#comments</comments>
		<pubDate>Wed, 03 Mar 2010 11:00:00 +0000</pubDate>
		<dc:creator>Arthritis / Rheumatology News From Medical News Today</dc:creator>
				<category><![CDATA[arthritis news]]></category>
		<category><![CDATA[Biologic Agents]]></category>
		<category><![CDATA[Genentech]]></category>
		<category><![CDATA[Infusion]]></category>
		<category><![CDATA[Launch]]></category>
		<category><![CDATA[Line Survey]]></category>
		<category><![CDATA[Niche]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Research Group]]></category>
		<category><![CDATA[Roche]]></category>

		<guid isPermaLink="false">http://mnt.to/f/3yps</guid>
		<description><![CDATA[BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch.  Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion.  The study results are based on an on-line survey completed by 77 rheumatologists in late February...<p><a href="http://www.sayno2arthritis.com/blog/rheumatologists-have-plenty-of-choice-among-biologic-agents-for-ra-where-will-actemra-find-its-niche/">Rheumatologists Have Plenty Of Choice Among Biologic Agents For RA &#8211; Where Will Actemra Find Its Niche?</a> is a post from: <a href="http://www.sayno2arthritis.com/blog">Arthritis Treated with Alternative Medicine</a></p>
]]></description>
		<wfw:commentRss>http://www.sayno2arthritis.com/blog/rheumatologists-have-plenty-of-choice-among-biologic-agents-for-ra-where-will-actemra-find-its-niche/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
